Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Infinity Pharmaceuticals -- Ignore unavailable to you. Want to Upgrade?

To: tuck who wrote (178)	2/24/2011 2:11:00 PM
From: scaram(o)uche	Respond to of 210

This sort of post is really appreciated.... as you know, I no longer poke around enough. Not close enough to stuff to see downside, but still really appreciate "tickler" posts re. potential upside. Missed most of the exel run to date, got off looking for a correction that never came. Nice position trade for the first part of the run, but.... !! This, after pointing early at gu-asco. Take gun, aim at toe, fire.

To: tuck who wrote (178)	2/24/2011 2:59:21 PM
From: rkrw	Read Replies (1) \| Respond to of 210

From what I understand the Calistoga compound has been doing very well in some B-cell lymphoma's. calistogapharma.com

To: tuck who wrote (178)	4/15/2011 4:29:39 PM
From: tuck	Respond to of 210

"I like that they have enough resources to get them past several inflection points." HHmmm. Infinity pulls the "let's do this on a Friday after hours and hope nobody notices" stunt. Files a mixed shelf, $100 million. Cheers, Tuck